| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/ploscb/HaseTSNK09 |
| P356 | DOI | 10.1371/JOURNAL.PCBI.1000550 |
| P932 | PMC publication ID | 2760708 |
| P698 | PubMed publication ID | 19876376 |
| P5875 | ResearchGate publication ID | 38054824 |
| P50 | author | So Nakagawa | Q39068698 |
| P2093 | author name string | Hiroshi Tanaka | |
| Takeshi Hase | |||
| Yasuhiro Suzuki | |||
| Hiroaki Kitano | |||
| P2860 | cites work | Towards a proteome-scale map of the human protein–protein interaction network | Q21735930 |
| Scale-free networks in cell biology | Q22306161 | ||
| A robustness-based approach to systems-oriented drug design | Q51062307 | ||
| A network solution | Q53527430 | ||
| Growing network with local rules: preferential attachment, clustering hierarchy, and degree correlations | Q73478873 | ||
| Scale-rich metabolic networks | Q81764933 | ||
| Disordered domains and high surface charge confer hubs with the ability to interact with multiple proteins in interaction networks | Q82855583 | ||
| DrugBank: a comprehensive resource for in silico drug discovery and exploration | Q24188653 | ||
| MPact: the MIPS protein interaction resource on yeast | Q24538008 | ||
| The human disease network | Q24678240 | ||
| Protein complexes and functional modules in molecular networks | Q24683305 | ||
| Network biology: understanding the cell's functional organization | Q27861027 | ||
| Collective dynamics of 'small-world' networks | Q27861064 | ||
| Global mapping of the yeast genetic interaction network | Q27934987 | ||
| Specificity and stability in topology of protein networks | Q28216450 | ||
| Drug-target network | Q29614447 | ||
| Evidence for dynamically organized modularity in the yeast protein-protein interaction network | Q29614449 | ||
| Stratus not altocumulus: a new view of the yeast protein interaction network | Q33258019 | ||
| The "robust yet fragile" nature of the Internet | Q34056048 | ||
| Quantitative systems-level determinants of human genes targeted by successful drugs. | Q36388813 | ||
| Network properties of genes harboring inherited disease mutations | Q36670355 | ||
| Towards a theory of biological robustness | Q42560167 | ||
| Birth of scale-free molecular networks and the number of distinct DNA and protein domains per genome. | Q48337100 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | protein design | Q410814 |
| protein structure | Q735188 | ||
| P304 | page(s) | e1000550 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | PLOS Computational Biology | Q2635829 |
| P1476 | title | Structure of protein interaction networks and their implications on drug design | |
| P478 | volume | 5 |
| Q34168896 | A computational model to predict bone metastasis in breast cancer by integrating the dysregulated pathways |
| Q38193097 | A conceptual review on systems biology in health and diseases: from biological networks to modern therapeutics |
| Q92496939 | A dual controllability analysis of influenza virus-host protein-protein interaction networks for antiviral drug target discovery |
| Q83307544 | A novel paradigm for potential drug-targets discovery: quantifying relationships of enzymes and cascade interactions of neighboring biological processes to identify drug-targets |
| Q38046230 | Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present). |
| Q53175427 | Assessing Relative Bioactivity of Chemical Substances Using Quantitative Molecular Network Topology Analysis |
| Q38243624 | Biological networks and drug discovery--where do we stand? |
| Q50420648 | Building protein-protein interaction networks for Leishmania species through protein structural information. |
| Q36477635 | Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2 |
| Q37784556 | Cause-effect relationships in medicine: a protein network perspective |
| Q51530606 | Challenges in the design of multitarget drugs against multifactorial pathologies: a new life for medicinal chemistry? |
| Q39768567 | Cross-Disciplinary Network Comparison: Matchmaking Between Hairballs |
| Q34552423 | Dissecting the human protein-protein interaction network via phylogenetic decomposition |
| Q28551715 | Distinctive Behaviors of Druggable Proteins in Cellular Networks |
| Q50934746 | Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden |
| Q36123974 | Diverse array-designed modes of combination therapies in Fangjiomics |
| Q35846066 | Drug Target Prediction Based on the Herbs Components: The Study on the Multitargets Pharmacological Mechanism of Qishenkeli Acting on the Coronary Heart Disease |
| Q30577213 | Effects of protein interaction data integration, representation and reliability on the use of network properties for drug target prediction. |
| Q36480634 | Evolutionary Model Selection and Parameter Estimation for Protein-Protein Interaction Network Based on Differential Evolution Algorithm |
| Q41495324 | Evolutionary analysis and interaction prediction for protein-protein interaction network in geometric space |
| Q30413339 | From QSAR models of drugs to complex networks: state-of-art review and introduction of new Markov-spectral moments indices |
| Q36565116 | Functional analysis of long intergenic non-coding RNAs in phosphate-starved rice using competing endogenous RNA network |
| Q40267048 | Identification of drug-target interaction from interactome network with 'guilt-by-association' principle and topology features |
| Q49363717 | Identification of prognostic signature in cancer based on DNA methylation interaction network |
| Q30000682 | Inferring gene dependency network specific to phenotypic alteration based on gene expression data and clinical information of breast cancer |
| Q41863562 | Inferring multi-target QSAR models with taxonomy-based multi-task learning. |
| Q45835957 | Integrated gene co-expression network analysis in the growth phase of Mycobacterium tuberculosis reveals new potential drug targets. |
| Q50511044 | Interactions of Hemoglobin in Live Red Blood Cells Measured by the Electrophoresis Release Test |
| Q50567915 | Interactions of hemoglobin in live red blood cells measured by the electrophoresis release test |
| Q35089917 | Intercellular Interactomics of Human Brain Endothelial Cells and Th17 Lymphocytes: A Novel Strategy for Identifying Therapeutic Targets of CNS Inflammation |
| Q92962253 | Measuring rank robustness in scored protein interaction networks |
| Q36938251 | Modeling and analysis of retinoic acid induced differentiation of uncommitted precursor cells |
| Q27444499 | Network connectivity during mergers and growth: Optimizing the addition of a module |
| Q28479003 | Network neighbors of drug targets contribute to drug side-effect similarity |
| Q60301188 | Network-Guided Discovery of Influenza Virus Replication Host Factors |
| Q27691333 | Network-based characterization of drug-regulated genes, drug targets, and toxicity |
| Q38066338 | On the functional and structural characterization of hubs in protein–protein interaction networks |
| Q36910814 | Proteome-wide Prediction of Self-interacting Proteins Based on Multiple Properties |
| Q43784080 | Reduction of Complex Signaling Networks to a Representative Kernel |
| Q28541382 | Robustness and evolvability of the human signaling network |
| Q27008867 | Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review |
| Q30577130 | SynSysNet: integration of experimental data on synaptic protein-protein interactions with drug-target relations |
| Q28082555 | Systems Biology for Smart Crops and Agricultural Innovation: Filling the Gaps between Genotype and Phenotype for Complex Traits Linked with Robust Agricultural Productivity and Sustainability |
| Q34223105 | Systems analysis of inflammatory bowel disease based on comprehensive gene information. |
| Q35864807 | Systems biology of fungal infection. |
| Q37860613 | Systems biology of tuberculosis |
| Q28534621 | Target Essentiality and Centrality Characterize Drug Side Effects |
| Q40513256 | Targets of drugs are generally, and targets of drugs having side effects are specifically good spreaders of human interactome perturbations |
| Q34508185 | Topology of molecular interaction networks |
| Q33588662 | VAN: an R package for identifying biologically perturbed networks via differential variability analysis |
| Q38011629 | Visualization of the interactome: what are we looking at? |
| Q47252941 | gene2drug: a Computational Tool for Pathway-based Rational Drug Repositioning |
Search more.